Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

55results about How to "Uniform release rate" patented technology

Controlled release type potassium ferrate composite as well as preparation method and application thereof

The invention discloses a controlled release type potassium ferrate composite as well as a preparation method and application thereof. The preparation method is as follows: by taking a high polymer which is biodegradable and environment-friendly as a framework material, dissolving the high polymer in a low-boiling point organic solvent, adding a pore-foaming agent, a dispersing agent and high-purity potassium ferrate, adding the mixture into a medium for emulsifying and curing, and filtering and drying the cured product to obtain the controlled release type potassium ferrate composite. The composite is in a water environment, so that a net-shaped duct structure is formed in an inert framework material by virtue of the hydrophilcity of the pore-foaming agent, and therefore, the potassium ferrate is effectively aided to release from the composite, and a problem that dissolution of active ingredients is affected due to texture compaction of the framework material is avoided; the composite is different from the conventional disposable oxidant, controllable in release speed in water, uniform in velocity, long in holding time, good in storage stability, and has wide application prospect on in-situ repairing polluted underground water.
Owner:SOUTH CHINA NORMAL UNIVERSITY

Mouth mucosa sustained-release preparation for treating oral and periodontal diseases by chlorhexidine

The invention relates to fields of a drug for treating a disease of cari oris mucosa, and preparation thereof, and particularly relates to a mouth mucosa sustained-release preparation for treating oral and periodontal diseases by chlorhexidine. The preparation is composed of a mouth mucosa contact layer and a non-adhesive seal layer; the mouth mucosa contact layer comprises the components of an antibiotic drug and an auxiliary material, of which the weight ratio is (2-20) to (80-98); the non-adhesive seal layer comprises the components of a non-adhesive low-water soluble high-molecular polymer; the non-adhesive low-water soluble high-molecular polymer is selected from polyving akohol; the mouth mucosa sustained-release preparation comprises the components of 4.0g of chlorhexidine, 12.0g of hydroxyethyl cellulose, 5.5g of modified starch, 7.0g of microcrystalline cellulose, 0.5g of grape essence and the balance of polyving akohol. The mouth mucosa sustained-release preparation has the advantages of being convenient to drug delivery, long in drug release time, even in drug release speed, strong in target, strong in mucosa adhesive force and the like; and the preparation method is simple to operate, low in cost, friendly to environment, and suitable for industrial production.
Owner:上海微丸医药开发有限公司

A kind of aromatherapy cigarette containing full-component tobacco extract and its preparation method

The invention belongs to the field of tobacco products and discloses a fragrance cigarette containing full-component tobacco extracts and a preparation method thereof. The fragrance cigarette containing the full-component tobacco extracts comprises functional components, carbon powder, plant fibers and a bonding agent, wherein the functional components include tobacco extracts and tobacco extract particles, the tobacco extract particles include at least two substrate layers with different tobacco extract contents, the substrate layers are coated layer by layer, the surfaces of the substrate layers are wrapped by coating layers, the substrate layers contain excipient, and the tobacco extract contents of the substrate layers in the tobacco extract particles are gradually reduced from inside to outside. According to the fragrance cigarette containing the full-component tobacco extracts, the tobacco components include the tobacco extracts and the tobacco extract particles, and the release processes of the tobacco extracts and the tobacco extract particles are complementary, so that the tobacco component content of the fragrance cigarette containing the full-component tobacco extracts is kept, and continuous and uniform taste is provided for consumers.
Owner:GUANGDONG BRANCH OF CHINA TOBACCO GENERAL

Preparation of lisinopril sustained-release tablets

The invention belongs to the technical field of medicine preparations, and discloses preparation of lisinopril sustained-release tablets. The lisinopril sustained-release tablets comprise, by weight, 1%-4% of lisinopril, 54%-66% of matrix materials, 18%-24% of pregelatinized starch, 14.2%-17.6% of microcrystalline cellulose and 0.4%-0.8% of magnesium stearate. The matrix materials are carbomer. The preparation of the lisinopril sustained-release tablets includes smashing the lisinopril according to the weight percentage, filtering the lisinopril via a 100-mesh sieve and then adding the lisinopril into a three-dimensional movable mixer; smashing the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate, filtering the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate via an 80-mesh sieve and then adding the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate into the three-dimensional movable mixer; mixing the lisinopril, the carbomer, the pregelatinized starch, the microcrystalline cellulose and the magnesium stearate with one another by the three-dimensional movable mixer for 30 minutes to obtain mixtures and then directly compressing the mixtures to obtain the lisinopril sustained-release tablets. The preparation has the advantages that the mixtures are directly compressed without coating, so that sustained-release effects can be realized; technologies are simple, and medicine is uniform in release speed.
Owner:LUOYANG JUSN PHARMA

Mouth mucosa sustained-release preparation for treating oral and periodontal diseases by chlorhexidine

The invention relates to fields of a drug for treating a disease of cari oris mucosa, and preparation thereof, and particularly relates to a mouth mucosa sustained-release preparation for treating oral and periodontal diseases by chlorhexidine. The preparation is composed of a mouth mucosa contact layer and a non-adhesive seal layer; the mouth mucosa contact layer comprises the components of an antibiotic drug and an auxiliary material, of which the weight ratio is (2-20) to (80-98); the non-adhesive seal layer comprises the components of a non-adhesive low-water soluble high-molecular polymer; the non-adhesive low-water soluble high-molecular polymer is selected from polyving akohol; the mouth mucosa sustained-release preparation comprises the components of 4.0g of chlorhexidine, 12.0g of hydroxyethyl cellulose, 5.5g of modified starch, 7.0g of microcrystalline cellulose, 0.5g of grape essence and the balance of polyving akohol. The mouth mucosa sustained-release preparation has the advantages of being convenient to drug delivery, long in drug release time, even in drug release speed, strong in target, strong in mucosa adhesive force and the like; and the preparation method is simple to operate, low in cost, friendly to environment, and suitable for industrial production.
Owner:上海微丸医药开发有限公司

Mouth mucosa drug sustained release preparation for treating mouth periodontal disease by doxycycline

The invention relates to drugs for treating mouth mucosa diseases and the manufacture field of the drugs for treating mouth mucosa diseases, in particular to a mouth mucosa drug sustained release preparation for treating a mouth periodontal disease by doxycycline. The preparation is composed of a mouth mucosa contacted layer and a non-adhesiveness sealing layer. The mouth mucosa contacted layer comprises, by weight, 2-20/80-98 of antibiotic drugs and auxiliary materials. The components of the non-adhesiveness sealing layer are non-adhesiveness low water-solubility high-molecular polymers. The non-adhesiveness low water-solubility high-molecular polymers are chosen from polyvinyl alcohol. The components of mouth mucosa drug sustained release preparation comprise 2.0g of methyl vinyl ether-maleic anhydride copolymers, 2.0g of polyoxyethylene, 2.0g of carboxymethyl cellulose sodium, 12.0g of natural starch, 2.0g of menthol and 0.5g of doxycycline, and the rest is poval. The mouth mucosa drug sustained release preparation has the advantages that drug delivering is convenient, drug releasing time is long, drug releasing speed is even, targeting is strong, and adhesive force with mucosas is strong. In addition, the manufacturing method is simple in operation, low in cost, environment-friendly and suitable for industrial production.
Owner:上海微丸医药开发有限公司

Biological fertilizer and preparation method thereof

InactiveCN112094153AEnhanced Nutrient LevelsReduce the effect of agglomerationOrganic fertilisersSolid/semi-solid fertilisersFertilizerNutrient
The invention relates to the technical field of biological fertilizers, and especially relates to a biological fertilizer and a preparation method thereof. An arc-shaped disc used for bearing the biological fertilizer comprises a carbon cover barrel, a carbon column barrel and an arc-shaped frame. Due to the fact that the added biological fertilizer is prone to loss to all positions in soil blocksunder the rainwater condition, the content of nutrients absorbed by crop root areas is reduced, nutrient supply in the crop growth process is affected, and then the use effect of the biological fertilizer is weakened. Therefore, the storage state of the biological fertilizer under different conditions of the natural environment is protected through the carbon structure of the arc-shaped disc, itis ensured that the biological fertilizer acts on a crop root system area in a land parcel, the release rate of nutrients in the biological fertilizer is balanced through gradual conversion of biological carbon nutrient substances by microbial florae in the crop growth process, the yield of the biological fertilizer is increased. and the time for finally decomposing the carbon structure of the mechanism is controlled to completely decompose the carbon structure in the biological fertilizer, so that the application effect of the biological fertilizer is improved.
Owner:何莉

Standard plate for detecting pollution release of decoration material as well as preparation and application of standard plate

The invention discloses a standard plate for detecting pollution release of a decoration material as well as preparation and application of the standard plate. The standard plate comprises a sealing outer sleeve, a wood plate assembly, a sealing upper cover and a sealing plug, a hole is formed in the bottom surface of the sealing outer sleeve, and the wood plate assembly is composed of a bottom plate, a core plate and a top plate, nested in the sealing outer sleeve and pressed and fixed by the sealing upper cover; the core plate contains a porous material, and radial channels are formed in the core plate; through holes are formed in the centers of the top plate and the sealing upper cover; a sealing plug is inserted into the through holes for sealing. When the standard plate is used, target pollutants are dropped into the through holes, and the target pollutants are diffused and dispersed into the porous material and other interstitial substances in the core plate through the channels by centrifugation and oscillation, so that the standard plate capable of uniformly and stably releasing the target pollutants is obtained. By changing the types and concentrations of the added target pollutants, the pollution release conditions of different product control materials can be detected.
Owner:雄安绿研检验认证有限公司

Mouth mucosa drug sustained release preparation for treating mouth periodontal disease by doxycycline

The invention relates to drugs for treating mouth mucosa diseases and the manufacture field of the drugs for treating mouth mucosa diseases, in particular to a mouth mucosa drug sustained release preparation for treating a mouth periodontal disease by doxycycline. The preparation is composed of a mouth mucosa contacted layer and a non-adhesiveness sealing layer. The mouth mucosa contacted layer comprises, by weight, 2-20 / 80-98 of antibiotic drugs and auxiliary materials. The components of the non-adhesiveness sealing layer are non-adhesiveness low water-solubility high-molecular polymers. The non-adhesiveness low water-solubility high-molecular polymers are chosen from polyvinyl alcohol. The components of mouth mucosa drug sustained release preparation comprise 2.0g of methyl vinyl ether-maleic anhydride copolymers, 2.0g of polyoxyethylene, 2.0g of carboxymethyl cellulose sodium, 12.0g of natural starch, 2.0g of menthol and 0.5g of doxycycline, and the rest is poval. The mouth mucosa drug sustained release preparation has the advantages that drug delivering is convenient, drug releasing time is long, drug releasing speed is even, targeting is strong, and adhesive force with mucosas is strong. In addition, the manufacturing method is simple in operation, low in cost, environment-friendly and suitable for industrial production.
Owner:上海微丸医药开发有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products